Korean mistletoe lectin-induced apoptosis in hepatocarcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53

Archives of Pharmacal Research

Volumn 25, Issue 1, 2002, Pages 93-101

  Lyu, Su Yun ^a   Choi, Sang Ho ^b   Park, Won Bong ^a  

^a Seoul Women University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Apoptosis; Bax; Bcl 2; Hepatocarcinoma; Korean mistletoe; Lectin; p21; p53; Telomerase

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; DNA; DNA FRAGMENT; ENZYME INHIBITOR; ONCOPROTEIN; PLANT MEDICINAL PRODUCT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; RIBOSOME INACTIVATING PROTEIN, VISCUM; TELOMERASE; TOXIN; TUMOR PROTEIN; VEGETABLE PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; CHEMISTRY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FLOW CYTOMETRY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KOREA; LIVER CELL CARCINOMA; MITOCHONDRION; PATHOLOGY; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASES; CELL NUCLEUS; DNA FRAGMENTATION; DNA, NEOPLASM; DOWN-REGULATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GENES, BCL-2; GENES, P53; HUMANS; KOREA; MITOCHONDRIA; NEOPLASM PROTEINS; ONCOGENE PROTEIN P21(RAS); PLANT PREPARATIONS; PLANT PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERASE; TOXINS, BIOLOGICAL; TUMOR CELLS, CULTURED;

EID: 0036480161     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02975269     Document Type: Article

References (39)

1. Antonsson, B. and Martinou, J. C., The Bcl-2 protein family. Exp. Cell Res., 256, 50-57 (2000).
2. Arenas, M. J., Mcgregor, A. H., and Wyllie, A. H., Apoptosis is inversely related to necrosis and determines the growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. J. Pathol., 144, 1045-1057 (1994).
3. Bantel, H., Engels, I. H., Voelter, W., Schulze-Osthoff, K., and Wesselborg, S., Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res., 59, 2083-2090 (1999).
4. Büssing, A., Biological and pharmacological properties of Viscum album L.; From tissue flask to man. In A. Bussing (eds.), Mistletoe, genus Viscum & other genera, Medicinal and aromatic plantslndustrial profiles. Harwood Academic Publishers, Netherland, pp 45-60, 2000.
5. Büssing, A., Suzar, K., Bergmann, J., Pfüller, U., Schietzel, M., and Schweizer, K., Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett., 99, 59-72 (1996).
6. Bussing, A., Vervecken, W., Wagner, M., Pfüller, U., and Schietzel, M., Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. Cytometry, 37, 133-139 (1999).
7. Eck, J., Langer, M., Moeckel, B., Baur, A., Rothe, M., Zinke, H., and Lentzen, H., Cloning of the mistletoe lectin gene and charaterization of the recombinant A-chain. Eur. J. Biochem. 264, 775-784 (1999a).
8. Eck, J., Langer, M., Moeckel,, B., Witthohn, K., Zinke, H., and Lentzen, H., Characterization of recombinant and plant-derived mistletoe lectin and their B-chains. Eur. J. Biochem. 265, 788-797 (1999b).
9. El-Deiry, W. S., Harper, J. W., OConner, P. M., Velculescu, C. E., and Canman, J., WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54, 1169-1174 (1994).
10. Finucane, D. M., Wetzel, B. B., Waterhouse, N. J., Gotter, T. G., and Green, D. R., Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibited by Bcl-xL. J. Biol. Chem., 274, 2225-2233 (1999).
11. Freshney, R. I., Cytotoxicity. In. R. I. Freshney (eds.), Culture of animal cells, a manual of basic technique. Wiley-Liss Press, Toronto, pp 329-344, 2000.
12. Green, D. R. and Martin, S. J., The killer and the executioner: how apoptosis controls malignancy. Curr. Opin. Immunol. 7, 694-703 (1995).
13. Hodes R, Molecular targeting of cancer: Telomeres as targets. Proc. Natl. Acad. Sci. USA, 98, 7649-7651 (2001).
14. Hofmann, B. and Reed, J. C., Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805 (1994).
15. Jiang, H., Lin, J., Su, Z., Collart, F. R., Hubermann, E., and Fisher, P. B., Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1 expression in the absence of p53. Oncogene 9, 3397-3406 (1994).
16. Jung, M. L., Baudino, S., and Beck, J. P., Charaterization of cytotoxic proteins from mistletoe (Viscum album L.). Cancer Lett., 51, 103-108 (1990).
17. Kano, A., Watanabe, Y., Takeda, N., Aizawa, S., and Akaike, T., Analysis of IFN-gamma-induced cell cycle arrest and cell death in heapatocytes. J. Biochem, 121, 677-683 (1997).
18. Kaufmann, S. H. and Earnshaw, W. C., Induction of apoptosis by cancer chemotherapy. Exp. Cell Res., 256, 42-49 (2000).
19. Kerr, J. F. R., Winterford, C. M., and Harmon, B. V., Apoptosis - its significance in cancer and cancer therapy. Cancer, 73, 2013-2026 (1994).
20. Kim, W. H., Kang, K. H., Kim, M. Y., and Choi, K. H., Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells. Biochem. Cell Biol., 78, 127-35 (2000).
21. Kim, W. H., Oh, W. J., Kang, K. H., Kim, T. Y., Kim, M. Y., and Choi, K. H., Induction of p21 during ceramide-mediated apoptosis in human hepatoccarcinoma cells. Cancer Lett, 129, 215-222 (1998).
22. L, or Bax in C6Bu-1 cells. Arc. Pharm. Res., 22, 448-453 (1999).
23. Kuirbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kasten, M. B., Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89, 7491-7495 (1992).
24. Lee, K. H., Rudolph, K. L., Ju, Y. J., Greenberg, R. A., Cannizzaro, L., Chin, L., Weiler, S. R., and DePinho, R. A., Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc. Natl. Acad. Sci. USA, 98, 3381-3386 (2001).
25. Liu, J. P., Studies on the molecular mechanisms in the regulation of telomerase activity. FASEB J., 13, 2091-2104 (1999).
26. Lowe, S. W. and Lin, A. W., Apoptosis in cancer. Carcinogenesis, 21, 485-495 (2000).
27. Lyu, S. Y., Park, S. M., Choung, B. Y., and Park, W. B., Comparative study of Korean (Viscum album, var. coloratum) and European mistletoes (Viscum album). Arch. Pharm. Res., 23, 592-598 (2000).
28. Lyu, S. Y., Park, W. B., Choi, K. H., and Kim, W. H., Involvement of caspase-3 in apoptosis induced by Viscum album var. coloratum agglutinin in HL-60 cells. Biosci. Biotechnol. Biochem., 65, 534-541 (2001)
29. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Miyashita, T., and Reed, J. C., Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299 (1995).
30. Park, C. H., Lee, D. W., Kang, T. B., Lee, K. H., Yoon, T. J., Kim, J. B., Do, M. S., and Song, S. K., cDNA cloning and sequence analysis of the lectin genes of the Korean mistletoe (Viscum album coloratum). Mol. Cells, 12, 215-220 (2001).
31. Park, W. B., Ju, Y. J., and Han, S. K., Isolation and characterization of -galactoside specific lectin from Korean mistletoe (Viscum album L, var. coloratum) with lactose-BSA-Sepharose 4B and changes of lectin conformation. Arch. Pharm. Res., 21, 429-435 (1998).
32. Park, W. B., Choung, B. Y., Park, S. M., Lee, T. S., Kim, J. H., and Ham, S. S., Antitumor activities of extracts and lectin from Viscum album L. and Viscum album var. coloratum on cultured HL-60 cells. Food Sci. Biotechnol., 8, 232-237 (1999a).
33. Park, W. B., Choung, B. Y., Park, S. M., Kim, H. S., and Lyu, S. Y., Effects of drying process of mistletoes on cytotoxicities against cultured HL-60 and Molt-4 cells, Food Sci. Biotechnol., 8, 391-396 (1999b).
34. Pendino, F., Flexor, M., Delhommeau, F., Buet, D., Lanotte, M., and Segal-Bendirdjian, E., Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc. Natl. Acad. Sci. USA, 98, 6662-6667 (2001).
35. Schwartz, L. M. and Osborn, B. A., Programmed cell death, apoptosis and killer genes. Immunol. Today, 14. 582-590 (1993).
36. Tereda, N., Lucas J. J., and Gelfand, E. W., Differential regulation of the tumor suppressor molecules, retinoblasma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol. 147, 698-704 (1991).
37. Wallace, B. R. R. and Lowe, S. W., Clinical implications of p53 mutations. Cell Mol Life Sci, 55, 64-75 (1999).
38. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M., Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature, 352, 345-347 (1991).
39. Yoon, T. J., Yoo, Y. C., Kang, T. B., Shimazki, K. Song, S. K., Lee, K. H., Kim, S. H., Park, C. H., Azuma, I., and Kim, J. B., Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells. Cancer Lett., 136, 33-40 (1999).